Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report

Deirdre F Waterhouse; Geraldine A Moloney; Fatma S Gargoum; Peter S Hayden; Tom OGorman

首页> 外文期刊>Cases Journal >Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report

【24h】

Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report

机译：最近的硼替佐米治疗后IgA-lambda骨髓瘤的髓外复发：一例报告

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Intracranial plasmacytomas are an uncommon presentation of extramedullary relapse of multiple myeloma. The optimal management of extramedullary plasmacytomas remains unclear, with initial reports of bortezomib showing promising clinical results. We describe a case of multiple extracellular, including intracranial, plasmacytoma, with no evidence of marrow involvement, in a patient with relapsed IgA multiple myeloma. To our knowledge, this is the first reported case of a patient with rapid extramedullary relapse of disease despite recent exposure to bortezomib and dexamethasone.

机译：颅内浆细胞瘤是多发性骨髓瘤髓外复发的罕见表现。尚无关于髓外浆细胞瘤的最佳治疗方法，硼替佐米的初步报道显示有希望的临床结果。 IgA多发性骨髓瘤复发的患者中，我们描述了多发性细胞外（包括颅内，浆细胞瘤）病例，无骨髓累及迹象。据我们所知，这是首次报告的病例，尽管最近接触了硼替佐米和地塞米松，但该疾病仍迅速发生了髓外复发。

著录项

来源
《Cases Journal》 |2009年第1期|共页
作者
Deirdre F Waterhouse; Geraldine A Moloney; Fatma S Gargoum; Peter S Hayden; Tom OGorman;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review [J] . Ricardo D. Parrondo, Vivek Roy, Taimur Sher, Case Reports in Hematology . 2020,第1期

机译：使用KRD-PACE作为攻击性的救生疗法，复发/ Bortezomib-Remracty extramedullary多发性骨髓瘤：一份报告两种病例和文献综述
2. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation | Haematologica [J] . F Patriarca, S Prosdocimo, V Tomadini, Haematologica . 2005,第2期

机译：硼替佐米治疗对自体和非清髓异体移植后骨髓瘤髓外复发的疗效血液学
3. Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clini [J] . Gotoh A, Ohyashiki K, Oshimi K, 臨床血液 . 2006,第12期

机译：在日本复发/难治性多发性骨髓瘤中与硼替佐米治疗相关的肺损伤：日本血液学会和日本克里尼学会联合委员会“基于硼替佐米的肺损伤”的问卷调查报告
4. Durability of Response with Thalidomide Therapy for Relapsed Multiple Myeloma [C] . B. Myers, S.G. Jones, G. Do I an European Haematology Association . 2002

机译：耐久性耐久性与多发性骨髓瘤复发疗法
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report [O] . Deirdre F Waterhouse, Geraldine A Moloney, Fatma S Gargoum, 2009

机译：最近的硼替佐米治疗后IgA-lambda骨髓瘤的髓外复发：一例报告
7. Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report [O] . 2009

机译：最近的硼替佐米治疗后IgA-lambda骨髓瘤的髓外复发：一例报告

Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report

摘要

著录项

相似文献

相关主题

期刊订阅